首页> 外国专利> Sustained release formulations for nifedipine, dextromethorphan, and danazol

Sustained release formulations for nifedipine, dextromethorphan, and danazol

机译:硝苯地平,右美沙芬和达那唑的缓释制剂

摘要

Disclosed herein are sustained release formulations of nifedipine and dextromethorphan that are compatible with a soft elastic gelatin capsule and a two-piece hard shell gelatin capsule. It has been discovered that specific lipids in the formulations can spontaneously form multilamellar liposomes upon introduction of the formulation to an aqueous environment. These spontaneously formed liposomes are stable under conditions that simulate the environment of the stomach and upper small intestine. The formulations can be administered orally, intra-ocularly, intranasally, rectally, or vaginally.
机译:本文公开了硝苯地平和右美沙芬的缓释制剂,其与软弹性明胶胶囊和两件式硬壳明胶胶囊相容。已经发现,在将制剂引入水性环境中时,制剂中的特定脂质可以自发形成多层脂质体。这些自发形成的脂质体在模拟胃和上小肠环境的条件下是稳定的。所述制剂可以口服,眼内,鼻内,直肠或阴道施用。

著录项

  • 公开/公告号US2003003144A1

    专利类型

  • 公开/公告日2003-01-02

    原文格式PDF

  • 申请/专利权人 KELLER BRIAN C.;

    申请/专利号US20020136957

  • 发明设计人 BRIAN C. KELLER;

    申请日2002-05-01

  • 分类号A61K9/127;A61K9/48;A61K9/64;

  • 国家 US

  • 入库时间 2022-08-22 00:07:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号